(Total Views: 640)
Posted On: 06/06/2022 10:41:14 AM
Post# of 155808
Re: craigakess #124221
craigakess, you posted a Yahoo article about Enhertu which noted that there were 3 deaths. A Reuters article gave a little more detail about the lung problems:
The drug, which is administered as an intravenous infusion, is not without safety concerns. It has been linked to a type of lung scarring called interstitial lung disease (ILD). Forty-five Enhertu patients in the trial had varying degrees of ILD versus one in the chemotherapy group.
Enhertu belongs to class of therapies called antibody drug conjugates (ADC), which are engineered antibodies that bind to tumour cells and release cell-killing chemicals.
https://www.reuters.com/business/healthcare-p...022-06-05/
The drug, which is administered as an intravenous infusion, is not without safety concerns. It has been linked to a type of lung scarring called interstitial lung disease (ILD). Forty-five Enhertu patients in the trial had varying degrees of ILD versus one in the chemotherapy group.
Enhertu belongs to class of therapies called antibody drug conjugates (ADC), which are engineered antibodies that bind to tumour cells and release cell-killing chemicals.
https://www.reuters.com/business/healthcare-p...022-06-05/
(3)
(0)
